NewAmsterdam Pharma reported revenue of $3.70M and net income of -$64.50M for the quarter ended Jun 2026, down 80.7% year over year. This income statement covers 16 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2021 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 24.13M | 81.56M | 81.77M | 82.32M | 82.47M | 82.47M | 89.72M | 90.02M | 92.17M | 108.06M | 112.17M | 112.51M | 113.17M | 114.40M | 116.64M | 117.65M |
| Revenue & cost | ||||||||||||||||
| Revenue | 8.63M | 1.72M | 2.94M | 0.80M | 1.40M | 2.28M | 29.11M | 12.77M | 2.98M | 19.14M | 0.35M | 0.03M | 3.04M | 3.70M | ||
| Operating items | ||||||||||||||||
| Research & DevelopmentR&D | 40.42M | 34.34M | 43.37M | 41.29M | 42.43M | 38.38M | 35.70M | 34.90M | 44.75M | 27.52M | 30.97M | 38.59M | 38.01M | 41.67M | ||
| Selling, General & AdministrativeSG&A | 8.06M | 9.86M | 9.13M | 10.59M | 14.45M | 16.48M | 18.41M | 21.11M | 27.15M | 27.26M | 24.52M | 27.42M | 23.45M | 26.89M | ||
| Other Operating ExpensesOther Opex | -0.00M | |||||||||||||||
| Operating ExpensesOpex | 48.48M | 44.20M | 52.50M | 51.88M | 56.88M | 54.85M | 54.11M | 56.00M | 71.90M | 54.78M | 55.49M | 66.01M | 61.46M | 68.56M | ||
| Operating IncomeOp. Inc | -39.85M | -42.48M | -49.56M | -51.07M | -55.48M | -52.58M | -25.00M | -43.23M | -68.92M | -35.63M | -55.14M | -65.98M | -58.42M | -64.86M | ||
| EBIT | -39.85M | -42.48M | -49.56M | -51.07M | -55.48M | -52.58M | -25.00M | -43.23M | -68.92M | -35.63M | -55.14M | -65.98M | -58.42M | -64.86M | ||
| Non-operating items | ||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.94M | 4.61M | 3.06M | 2.67M | 3.08M | 4.87M | 4.44M | 4.49M | 7.35M | 7.05M | 6.71M | 6.47M | 5.65M | 5.81M | ||
| Other Non Operating IncomeOther Non Op Inc. | 3.07M | -0.07M | -3.15M | 5.22M | -2.42M | -0.99M | 4.68M | -7.87M | 4.29M | 8.63M | 0.22M | -0.08M | -1.61M | -0.53M | ||
| Net income details | ||||||||||||||||
| EBT | -42.02M | -38.29M | -47.13M | -49.47M | -93.77M | -39.01M | -16.65M | -92.18M | -39.53M | -17.36M | -72.00M | -74.92M | -48.44M | -64.14M | ||
| Tax ProvisionsTaxes | -0.00M | |||||||||||||||
| Profit After TaxPAT | -42.02M | -38.29M | -47.13M | -49.49M | -93.77M | -39.01M | -16.65M | -92.18M | -39.56M | -17.47M | -72.00M | -74.92M | -49.01M | -64.50M | ||
| Income from Continuing OperationsIncome (Continuing) | -42.02M | -38.29M | -47.13M | -49.47M | -93.77M | -39.01M | -16.65M | -92.18M | -39.53M | -17.36M | -72.00M | -74.92M | -48.44M | -64.14M | ||
| Consolidated Net IncomeConsol Net Inc. | -42.02M | -38.29M | -47.13M | -49.47M | -93.77M | -39.01M | -16.65M | -92.18M | -39.53M | -17.36M | -72.00M | -74.92M | -48.44M | -64.14M | ||
| Income towards Parent CompanyParent Net Inc | -42.02M | -38.29M | -47.13M | -49.47M | -93.77M | -39.01M | -16.65M | -92.18M | -39.53M | -17.36M | -72.00M | -74.92M | -48.44M | -64.14M | ||
| Net Income towards Common StockholdersNet Income | -42.02M | -38.29M | -47.13M | -49.47M | -93.77M | -39.01M | -16.65M | -92.18M | -39.53M | -17.36M | -72.00M | -74.92M | -48.44M | -64.14M | ||
| Additional items | ||||||||||||||||
| EPS (Basic) | -0.51 | -0.47 | -0.57 | -0.60 | -1.06 | -0.41 | -0.18 | -0.98 | -0.34 | -0.15 | -0.61 | -0.63 | -0.40 | -0.52 | ||
| EPS (Diluted) | -0.51 | -0.47 | -0.57 | -0.60 | -1.06 | -0.41 | -0.18 | -0.98 | -0.34 | -0.15 | -0.61 | -0.63 | -0.40 | -0.52 | ||
| Shares Outstanding | 24.13M | 81.56M | 81.63M | 82.06M | 82.47M | 82.16M | 88.38M | 94.71M | 94.75M | 94.36M | 116.12M | 118.56M | 119.00M | 118.42M | 121.72M | 123.37M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 11.33M | 18.97M | 81.63M | 82.06M | 82.47M | 82.16M | 88.38M | 94.71M | 94.75M | 94.36M | 116.12M | 118.56M | 119.00M | 118.42M | 121.72M | 123.37M |
| EBITDA | -39.85M | -42.48M | -49.56M | -51.07M | -55.48M | -52.58M | -25.00M | -43.23M | -68.92M | -35.63M | -55.14M | -65.98M | -58.42M | -64.86M | ||
| Tax Rate | 0.01 |